An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

Abstract Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encomp...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony Yazdani, Alban Bornet, Philipp Khlebnikov, Boya Zhang, Hossein Rouhizadeh, Poorya Amini, Douglas Teodoro
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Data
Online Access:https://doi.org/10.1038/s41597-025-04718-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41597-025-04718-1

Similar Items